Addus HomeCare (NASDAQ:ADUS) Insider Heather Brianne Dixon Sells 288 Shares

Addus HomeCare Corporation (NASDAQ:ADUS) insider Heather Brianne Dixon sold 288 shares of Addus HomeCare stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $93.77, for a total transaction of $27,005.76. Following the sale, the insider owned 44,371 shares of the company’s stock, valued at $4,160,668.67. The trade was a 0.64% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Addus HomeCare Price Performance

Addus HomeCare stock opened at $96.09 on Wednesday. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.83 and a quick ratio of 1.83. The stock has a market cap of $1.79 billion, a price-to-earnings ratio of 17.76, a price-to-earnings-growth ratio of 1.30 and a beta of 0.89. The firm has a 50-day moving average of $94.05 and a two-hundred day moving average of $101.97. Addus HomeCare Corporation has a 1 year low of $87.95 and a 1 year high of $124.43.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, May 4th. The company reported $1.62 EPS for the quarter, topping analysts’ consensus estimates of $1.52 by $0.10. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The business had revenue of $363.50 million for the quarter, compared to analyst estimates of $366.41 million. During the same period last year, the company posted $1.42 earnings per share. The company’s quarterly revenue was up 7.7% compared to the same quarter last year. On average, research analysts forecast that Addus HomeCare Corporation will post 6.24 earnings per share for the current year.

Institutional Trading of Addus HomeCare

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Global Retirement Partners LLC raised its position in shares of Addus HomeCare by 395.7% in the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after acquiring an additional 186 shares in the last quarter. Larson Financial Group LLC boosted its position in Addus HomeCare by 133.3% during the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after purchasing an additional 136 shares in the last quarter. Acumen Wealth Advisors LLC bought a new stake in Addus HomeCare during the fourth quarter valued at about $29,000. Private Trust Co. NA boosted its position in Addus HomeCare by 65.5% during the fourth quarter. Private Trust Co. NA now owns 283 shares of the company’s stock valued at $30,000 after purchasing an additional 112 shares in the last quarter. Finally, Arax Advisory Partners grew its stake in Addus HomeCare by 95.8% in the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after purchasing an additional 137 shares during the last quarter. Institutional investors own 95.35% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on ADUS shares. Stephens decreased their target price on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a research report on Wednesday, February 25th. KeyCorp reissued an “overweight” rating on shares of Addus HomeCare in a research report on Wednesday, February 25th. Weiss Ratings lowered Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 22nd. Royal Bank Of Canada restated an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a report on Wednesday, February 25th. Finally, Citizens Jmp reaffirmed a “market outperform” rating and issued a $142.00 price objective on shares of Addus HomeCare in a research note on Monday, May 18th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Addus HomeCare has an average rating of “Moderate Buy” and a consensus target price of $131.00.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.